Organization
Oslo University Hospital, Department of Oncology, Oslo, Norway
1 abstract
Abstract
ARTHRITIS PHENOTYPE FOLLOWING CHECK POINT INHIBITION IS UNSPECIFIC AND SERONEGATIVE IN MOST PATIENTS – RESULTS FROM THE PROSPECTIVE OBSERVATIONAL RIMRA STUDYOrg: Diakonhjemmet Hospital, Center for treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Oslo, Norway, Ålesund Hospital, Department of Rheumatology, Ålesund, Norway, Sorlandet Hospital, Division of Rheumatology, Department of Medicine, Kristiansand, Norway, University Hospital of North Norway, Department of Rheumatology, Tromsø, Norway, Oslo University Hospital, Department of Oncology, Oslo, Norway,